¸¸¼º CÇü°£¿°¿¡ °üÇÑ Á÷Á¢ÀÛ¿ëÇ×¹ÙÀÌ·¯½º Ä¡·á ÈÄ È£ÀüµÈ ³Ä¡¼º °£¼º Èä¼ö
fractory Hepatic Hydrothorax in Chronic Hepatitis C Controlled by Direct-acting Antivirals
±è¸íÈñ, ±è´ö±â, ÀºÇõ¼ö, ·ù¿ì¼±, ±è¼®Çö, À̺´¼®,
¼Ò¼Ó »ó¼¼Á¤º¸
±è¸íÈñ ( Kim Myung-Hee )
Ãæ³²´ëÇб³º´¿ø ¼Òȱ⳻°ú
±è´ö±â ( Kim Duk-Ki )
Ãæ³²´ëÇб³º´¿ø ¼Òȱ⳻°ú
ÀºÇõ¼ö ( Eun Hyuk-Soo )
Ãæ³²´ëÇб³º´¿ø ¼Òȱ⳻°ú
·ù¿ì¼± ( Rou Woo-Sun )
Ãæ³²´ëÇб³º´¿ø ¼Òȱ⳻°ú
±è¼®Çö ( Kim Seok-Hyun )
Ãæ³²´ëÇб³º´¿ø ¼Òȱ⳻°ú
À̺´¼® ( Lee Byung-Seok )
Ãæ³²´ëÇб³º´¿ø ¼Òȱ⳻°ú
Abstract
Hepatic hydrothorax is a transudative pleural effusion that complicates advanced liver cirrhosis. Patients refractory to medical treatment plus salt restriction and diuretics are considered to have refractory hepatic hydrothorax and may require transjugular intrahepatic portosystemic shunt (TIPS) or liver transplant. Successful antiviral therapy reduces the incidence of some complications of cirrhosis secondary to HCV infection. We report a case of hepatic hydrothorax in a 55-year-old female patient with HCV cirrhosis, which exhibited a spontaneous decrease in pleural effusion after direct antiviral agent (DAA) therapy. In cases of HCV cirrhosis, DAAs are worth administering before treatment by TIPS or liver transplantation.
Å°¿öµå
Hydrothorax; Liver cirrhosis; Hepacivirus; Pleural effusion
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸